EDGAR Filing Documents for 0001493152-18-011255

Form 8-K - Current report:

SEC Accession No. 0001493152-18-011255

Filing Date

2018-08-09

Accepted

2018-08-09 15:37:57

Documents

Period of Report

2018-08-04

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	26517
2		ex99-1.htm	EX-99.1	14182
	Complete submission text file	0001493152-18-011255.txt		42028

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733

Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 000-51476 | Film No.: 181004811
SIC: 2834 Pharmaceutical Preparations